Sarepta Therapeutics shares owned by Marshall Wace North America
Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Marshall Wace North America
from 13F filings
Historical chart of Marshall Wace North America investment in Sarepta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics held by Marshall Wace North America consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Sarepta Therapeutics by Marshall Wace North America
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2021-09-30 | $33M | 360k | 92.48 |
2021-06-30 | $40M | 508k | 77.74 |
2021-03-31 | $31M | 416k | 74.53 |
2020-12-31 | $1.6M | 9.4k | 170.53 |
2020-06-30 | $1.3M | 8.0k | 160.29 |
2019-12-31 | $7.3M | 57k | 129.04 |
2019-09-30 | $192k | 2.5k | 75.42 |
2019-06-30 | $3.8M | 25k | 151.94 |
2019-03-31 | $27M | 223k | 119.19 |
2018-12-31 | $19M | 173k | 109.13 |
2018-09-30 | $25M | 157k | 161.51 |
2018-06-30 | $37M | 280k | 132.18 |
2018-03-31 | $27M | 366k | 74.09 |
2017-12-31 | $14M | 245k | 55.64 |
2017-09-30 | $17M | 378k | 45.00 |
2017-06-30 | $449k | 13k | 33.99 |
More positions owned by Marshall Wace North America
View all positions for Marshall Wace North America